These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28847636)

  • 21. Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
    Dhana A; Hamada Y; Kengne AP; Kerkhoff AD; Broger T; Denkinger CM; Rangaka MX; Gupta-Wright A; Fielding K; Wood R; Huerga H; Rücker SCM; Bjerrum S; Johansen IS; Thit SS; Kyi MM; Hanson J; Barr DA; Meintjes G; Maartens G
    J Infect; 2022 Jul; 85(1):40-48. PubMed ID: 35588942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
    Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa.
    Gupta-Wright A; Ha H; Abdulgadar S; Crowder R; Emmanuel J; Mukwatamundu J; Marcelo D; Phillips PPJ; Christopher DJ; Nhung NV; Theron G; Yu C; Nahid P; Cattamanchi A; Worodria W; Denkinger CM;
    Lancet Glob Health; 2024 Feb; 12(2):e226-e234. PubMed ID: 38245113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.
    Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children.
    Pohl C; Rutaihwa LK; Haraka F; Nsubuga M; Aloi F; Ntinginya NE; Mapamba D; Heinrich N; Hoelscher M; Marais BJ; Jugheli L; Reither K
    J Infect; 2016 Oct; 73(4):326-35. PubMed ID: 27394403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya.
    Cavanaugh JS; Modi S; Musau S; McCarthy K; Alexander H; Burmen B; Heilig CM; Shiraishi RW; Cain K
    PLoS One; 2016; 11(3):e0152364. PubMed ID: 27023213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
    Huerga H; Bastard M; Lubega AV; Akinyi M; Antabak NT; Ohler L; Muyindike W; Taremwa IM; Stewart R; Bossard C; Nkosi N; Ndlovu Z; Hewison C; Stavia T; Okomo G; Ogoro JO; Ngozo J; Mbatha M; Aleny C; Wanjala S; Musoke M; Atwine D; Ascorra A; Ardizzoni E; Casenghi M; Ferlazzo G; Nakiyingi L; Gupta-Wright A; Bonnet M
    Lancet Glob Health; 2023 Jan; 11(1):e126-e135. PubMed ID: 36521944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    Shapiro AE; Hong T; Govere S; Thulare H; Moosa MY; Dorasamy A; Wallis CL; Celum CL; Grosset J; Drain PK
    AIDS; 2018 Aug; 32(13):1811-1820. PubMed ID: 29847333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis.
    Dhana A; Hamada Y; Kengne AP; Kerkhoff AD; Rangaka MX; Kredo T; Baddeley A; Miller C; Gupta-Wright A; Fielding K; Wood R; Huerga H; Rücker SCM; Heidebrecht C; Wilson D; Bjerrum S; Johansen IS; Thit SS; Kyi MM; Hanson J; Barr DA; Meintjes G; Maartens G
    Lancet HIV; 2022 Apr; 9(4):e233-e241. PubMed ID: 35338834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: A diagnostic case-control study.
    Moreira FMF; Verma R; Pereira Dos Santos PC; Leite A; da Silva Santos A; de Araujo RCP; da Silva BO; de Sá Queiroz JHF; Persing DH; Södersten E; Gnanashanmugam D; Khatri P; Croda J; Andrews JR
    EClinicalMedicine; 2021 Mar; 33():100776. PubMed ID: 33842866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy Study of a Novel Blood-Based Assay for Identification of Tuberculosis in People Living with HIV.
    Södersten E; Ongarello S; Mantsoki A; Wyss R; Persing DH; Banderby S; Strömqvist Meuzelaar L; Prieto J; Gnanashanmugam D; Khatri P; Schumacher SG; Denkinger CM
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
    PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    Gils T; Kamele M; Madonsela T; Bosman S; Ngubane T; Joseph P; Reither K; Bresser M; Vlieghe E; Decroo T; Ayakaka I; Lynen L; Van Heerden A
    PLoS One; 2023; 18(12):e0296197. PubMed ID: 38134020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.